Mirae Asset Global Etfs Holdings Ltd. Caribou Biosciences, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.4 Billion
- Q1 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Caribou Biosciences, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 168,610 shares of CRBU stock, worth $177,040. This represents 0.0% of its overall portfolio holdings.
Number of Shares
168,610
Previous 176,654
4.55%
Holding current value
$177,040
Previous $280,000
45.36%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding CRBU
# of Institutions
136Shares Held
47.1MCall Options Held
17.1KPut Options Held
58.1K-
Black Rock Inc. New York, NY6.95MShares$7.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.52MShares$4.75 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ3.27MShares$3.43 Million0.25% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA2.51MShares$2.63 Million0.18% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY2.35MShares$2.47 Million0.01% of portfolio
About Caribou Biosciences, Inc.
- Ticker CRBU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,840,800
- Market Cap $63.9M
- Description
- Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...